Advanced Search >

Risk Minimisation Materials

Prescribers Guide

This material has been developed to increase understanding of the recommendations in order to minimise the risk of serious liver adverse reactions when treated with Agomelatine. The Prescriber Guide includes guidance for Healthcare Professionals in monitoring the liver function of patients before and during treatment and important information regarding the interaction with potent CYP1A2 inhibitors.

For Healthcare Professionals

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue